XNAS: INCY
Incyte Live Stock Price Today, Share Analysis and Chart
about
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheuma...
Read More
126.93
2.28
(1.83%)
1.6M
XNAS Volume
XNAS 22 Sep, 2026 5:30 PM (EDT)
Partnership
Incyte expands Specialised Therapeutics partnership to launch its eczema treatment in Australia
See details
Medium Financial Strength
Mid Valuation
Technically Moderately Bullish
Turnaround Potential
These stocks have average financials and valuation, but strong momentum indicating buying interest
View Similar
Embed DVM
Incyte Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..